Keyphrases
Advanced Stage
16%
After Surgery
16%
Ascites
33%
Before Surgery
16%
Benign Ovarian Tumor
33%
Blood Donors
16%
Clinical Diagnosis
16%
Clinical Prognosis
33%
Diagnosis Treatment
16%
Enzyme-linked Immunosorbent Assay (ELISA)
16%
Epithelial Ovarian Cancer
16%
Factor Level
100%
Healthy Individuals
16%
Healthy Women
16%
Human Ovarian Cancer
16%
Ovarian Cancer
100%
Ovarian Cancer Patients
16%
Ovarian Carcinoma
66%
Ovarian Metastasis
16%
Ovarian Tumor
33%
Patient Survival
100%
Patient Tumor
16%
Poor Differentiation
16%
Serum Biomarkers
16%
Serum Levels
16%
Serum Vascular Endothelial Growth Factor
100%
Serum VEGF
100%
Survival Time
16%
Therapy Efficacy
100%
Tumor Growth
16%
Tumor Marker
16%
Tumor Metastasis
100%
Tumor Patients
100%
Tumor Progression
16%
Vascular Endothelial Growth Factor
66%
Vascular Endothelial Growth Factor Expression
16%
VEGF Levels
50%
Well-differentiated
16%
Medicine and Dentistry
Ascites
15%
Biological Marker
7%
Blood Donor
7%
Clinical Stage
100%
Enzyme Linked Immunosorbent Assay
7%
Krukenberg Tumor
38%
Metastatic Carcinoma
100%
Ovarian Cancer
100%
Ovarian Tumor
38%
Sensitivity and Specificity
7%
Survival Time
7%
Tumor Marker
7%
Tumor Progression
15%
Vasculotropin
100%
Pharmacology, Toxicology and Pharmaceutical Science
Ascites
15%
Biological Marker
7%
Enzyme-Linked Immunosorbent Assay
7%
Metastasis
100%
Ovary Cancer
100%
Ovary Carcinoma
38%
Ovary Tumor
38%
Survival Time
7%
Tumor Growth
15%
Tumor Marker
7%
Vasculotropin
100%